NCT00046462View on ClinicalTrials.gov

Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

November 30, 2004

Study Completion Date

December 31, 2004

Conditions
Diabetes Mellitus
Interventions
DRUG

Lantus (insulin glargine [rDNA origin] injection)

DRUG

Metformin

DRUG

Glyburide

DRUG

Thiazolidinedione

Trial Locations (1)

08807

Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY